Revisiting the concept of phenotypically distinct malignant pancreatic stem-cell subsets based on limiting dilution transplantation assays.
Thierry
T
Bonnefoix
Mary
M
Callanan
D014408:Biomarkers, Tumor / Q000032:analysis*; D051927:CD24 Antigen / Q000032:analysis; D002469:Cell Separation; D006801:Humans; D018960:Hyaluronan Receptors / Q000032:analysis; D016130:Immunophenotyping; D008565:Membrane Proteins / Q000032:analysis; D008954:Models, Biological; D009368:Neoplasm Transplantation; D014411:Neoplastic Stem Cells / Q000276:immunology* / Q000473:pathology; D010190:Pancreatic Neoplasms / Q000276:immunology* / Q000473:pathology; D010641:Phenotype; D015203:Reproducibility of Results
D014408:Biomarkers, Tumor; D051927:CD24 Antigen; C497889:CD24 protein, human; C497483:CD44 protein, human; D018960:Hyaluronan Receptors; D008565:Membrane Proteins; C106354:flotillins